Anaphylaxis during general anaesthesia: Prevention and management

CNS Drugs

Volumn 14, Issue 2, 2000, Pages 115-133

  Mertes, P M ^a   Laxenaire, M C ^b  

^a HÔPITAL MAISON BLANCHE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATRACURIUM; ATROPINE; DOBUTAMINE; GALLAMINE TRIETHIODIDE; HAPTEN; IMMUNOGLOBULIN E; LATEX; MIVACURIUM; MUSCLE RELAXANT AGENT; PANCURONIUM BROMIDE; PROSTAGLANDIN E1; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ALLERGY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ATOPY; BRONCHOSPASM; CELL ACTIVATION; CORTICOSTEROID THERAPY; CROSS REACTION; DISEASE CONTROL; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EMERGENCY SURGERY; FLOW CYTOMETRY; GENERAL ANESTHESIA; HEART FAILURE; HIGH RISK PATIENT; HISTAMINE RELEASE; HUMAN; MUSCLE RELAXATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SKIN TEST;

EID: 0033850920     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200014020-00003     Document Type: Article

References (193)

1. De l'action anaphylactique de certains venins
2. Histamine release by compounds of simple chemical structure
3. Adverse reactions to intravenous induction agents
4. Histamine release in man by propanidid (Epontol), gelatin (Haemaccel), histalog, pentagastrin and insulin
5. Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: Studies in the conscious human subject
6. Anaphylaxis to suxamethonium: A case report
7. Intradermal testing after severe histamine reactions to intravenous drugs used in anaesthesia
8. Trois cas de choc anaphylactique a la Celocurine
9. Anaphylactic type of accidents due to myorelaxing agents during general anesthesia: Clinical and biological study
10. Anaphylactoid reactions during anaesthesia: Seven years' experience of intradermal testing
11. Prick tests in the diagnosis of anaphylaxis to general anaesthetics
12. Intradermal testing after anaphylactoid reaction to anaesthetic drugs: Practical aspects of performance and interpretation
13. Substituted ammonium ions as allergenic determinants in drug allergy
14. Anaphylactoid reactions to neuromuscular blockers: Major role of IgE antibodies and possible contribution of IgE-independent mechanisms
15. Allergy to thiopentone
16. Life-threatening anaphylactoid reactions to propofol (diprivan)
17. Encore et toujours l'allergie
18. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia
19. Epidemiologie des reactions anaphylactoides peranesthesiques. Quatrieme enquete multicentrique (juillet 1994-decembre 1996)
20. Intradermal drug testing following anaphylactoid reactions during anaesthesia
21. Anaphylactic/anaphylactold reactions to anaesthetic and associated agents: Skin prick tests in aetiological diagnosis
22. Anaphylaxis during induction of general anesthesia: Subsequent evaluation and management
23. Allergic reactions during general anesthesia (GA)
24. Anaphylactic and anaphylactoid reactions in the perioperative period
25. Adverse reaction to neuromuscular blockers: Frequency, investigation, and epidemiology
26. Allergy and anaesthesia
27. The risk of allergy related to general anaesthesia
28. Intraoperative anaphylaxis: An association with latex sensitivity
29. Allergic reaction to latex: A risk factor for unsuspected anaphylaxis
30. Anaphylactic reactions to muscle relaxants
31. Anaphylaxis to mivacurium
32. Anaphylactic reaction to rocuronium bromide
33. Severe anaphylactic reactions to rocuronium bromide
34. Severe anaphylactic reaction to cisatracurium
35. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia: A French multicenter epidemiological inquiry
36. Substances responsible for peranesthetic anaphylactic shock: A third French multicenter study (1992-94)
37. Mast cell tryptase in anaesthetic anaphylactoid reactions
38. Anaphylaxis during anaesthesia: Current aspects of diagnosis and prevention
39. Prevalence of muscle relaxant sensitivity in a general population: Implications for a preoperative screening
40. Prospective study of the latent sensitization to muscle relaxants
41. Prospective study of sensitization to muscle relaxants
42. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs
43. Early biological markers of anaphylactoid reactions occurring during anesthesia
44. Biochemical markers of anaphylactoid reactions to drugs: Comparison of plasma histamine and tryptase
45. Pathogenesis of allergic reactions to anaesthetic drugs
46. Immunochemical particularities of anaphylactic reactions to compounds used in anesthesia
47. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
48. Selective interaction of Ni with an MHC-bound peptide
49. Direct Ni2+ antigen formation on cultured human dendritic cells
50. Anaphylaxis to muscle relaxants: Cross sensitivity between relaxants
51. Anaphylactic reactions to muscle relaxants under general anesthesia
52. Drug allergenic determinants
53. Allergy to muscle relaxants
54. Anaphylaxis to muscle-relaxant drugs: Study of cross-reactivity by skin tests
55. Anaphylactoid reactions to narcotic analgesics
56. The diagnosis of fatal anaphylactic reactions during anaesthesia: Employment of immunoassays for mast cell tryptase and drug-reactive IgE antibodies
57. Allergic reactions during anesthesia
58. Heterogeneity of human mast cells and basophils in response to muscle relaxants
59. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse
60. Treatment of acute anaphylaxis
61. Incidence and severity of anaphylactoid reactions to colloid volume substitutes
62. Biphasic systemic anaphylaxis: An inpatient and outpatient study
63. Anaphylaxis to latex during surgery
64. Anaphylactic and anaphylactoid reactions: Clinical presentation
65. Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms: A French multicenter prospective study
66. Epidemiology, diagnosis, precautions, and policies of intraoperative anaphylaxis to latex
67. Anaphylactic reaction to local administration of rifamycin SV
68. Anaphylactic shock after tourniquet removal in orthopedic surgery
69. Immediate hypersensitivity-type reactions in anaesthesia: Allergy or otherwise, a problem or an overstatement
70. Munich consensus development conference on histamine determination
71. Evaluation of mast cell activation (tryptase) in two patients suffering from drug-induced hypotensoid reactions
72. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells
73. Anaphylaxis to muscle relaxants: Predictive tests
74. Persistence of allergy to anaesthetic drugs
75. Le risque allergique en anesthesie-reanimation
76. Intradermal compared with prick testing in the diagnosis of anaesthetic allergy
77. Skin tests in diagnosis of allergy to muscle relaxants and other anaesthetic drugs
78. Comparative cutaneous histamine release by neuromuscular blocking agents
79. Cross-reactivity of rocuronium with other neuromuscular blocking agents
80. Anaphylaxis to muscle relaxants: Cross-sensitivity studied by radioimmunoassays compared to intradermal tests in 34 cases
81. Histaminoid reactions in anaesthesia
82. Anaphylactic anaesthetic reactions: The value of paper radioallergosorbent tests for IgE antibodies to muscle relaxants and thiopentone
83. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs
84. Biological tests for diagnosing the IgE-mediate allergy to anaesthetic drugs
85. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants
86. Histamine release assay and radioimmunoassay for the detection of IgE antibodies against neuromuscular blocking drugs
87. Evaluation clinique et biologique d'un test radio-immunologique de detection des IgE seriques specifiques des curarisants
88. Simultaneous anaphylaxis to thiopentone and a neuromuscular blocker: A study of two cases
89. Non-specific cross-reactivity of hydrophobic serum IgE to hydrophobic drugs
90. L'allergie au latex
91. Clinical evaluation of in vitro leukocyte histamine release in allergy to muscle relaxant drugs
92. Analysis of membrane expression of the CD63 human basophil activation marker: Applications to allergologic diagnosis
93. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy
94. Allergo-anesthesia consultation: Not enough patients are tested after an anaphylactoid anesthetic incident
95. The prevention of second anaphylactoid reactions to anaesthetic drugs
96. Atopy and anaphylactic reactions to suxamethonium
97. Histamine release from basophil leukocytes in asthma patients after in vitro provocation with various neuromuscular blocking drugs and intravenous anaesthetic agents
98. Spontaneous histamine release and histamine content in normal subjects and subjects with asthma
99. Basophil histamine release in atopic patients after in vitro provocation with thiopental, diprivan and chlormethiazole
100. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine
101. Natural latex, grass pollen, and weed pollen share IgE epitopes
102. Prospective study of risk factors in natural rubber latex hypersensitivity
103. A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: Epidemiologic features, risk factors, and latex hypersensitivity
104. The prevalence of latex sensitivity among anesthesiology staff
105. The incidence of latex sensitivity in ambulatory surgical patients: A correlation of historical factors with positive serum immunoglobin E levels
106. Allergic reaction caused by local anesthetic agents belonging to the amide group
107. Anaphylactic shock following intravenous administration of lignocaine
108. Alleged allergy to local anaesthetics
109. Anaphylactic reaction after cisatracurium
110. Predictive value of intradermal tests using muscle-relaxing drugs
111. Subsequent general anaesthesia in patients with a history of previous anaphylactoid/anaphylactic reaction to muscle relaxant
112. Anaphylactoid reactions during anaesthesia
113. Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia
114. Latex allergy manifested in urological surgery and care of adult spinal cord injured patients
115. Evaluation and risk factors of latex allergy in spina bifida patients: Is it preventable?
116. Rubber anaphylaxis
117. Anaesthesia for the allergic patient
118. Latex sensitivity in dental students and staff: A cross-sectional study
119. Factors that influence the presence of symptoms caused by latex allergy in children with spina bifida
120. Association between latex sensitization and repeated latex exposure in children
121. Natural rubber latex allergy in children who had not undergone surgery and children who had undergone multiple operations
122. 'Latex-fruit syndrome': Frequency of cross-reacting IgE antibodies
123. Anaphylactoid reactions to neuromuscular blocking agents: A commonly undiagnosed condition?
124. Fatal anaphylactic reaction to suxamethonium: New screening test suggests possible prevention
125. Fatal reaction to suxamethonium: Case for screening by radioallergosorbent test?
126. Prevalence of latex sensitization in subjects attending health screening: Implications for a perioperative screening
127. Adverse reactions and interactions of the neuromuscular blocking drugs
128. Adverse reactions to plasma volume expanders
129. Histamine release in anaesthetic and surgery: A new method to evaluate its clinical significance with several types of causal relationship
130. Direct histamine release in anaesthesia and surgery: Unanswered questions
131. Discussion forum about a protocol of a controlled clinical trial: Induction of anaesthesia and perioperative risk
132. Perioperative uses of histamine antagonists
133. Histamine inhibition of concanavalin A-induced suppressor T-cell activation
134. Inhibition of histamine release by histamine controlled by H2 receptor
135. The effects of H1- and H2-receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis
136. The effect of ranitidine, alone and in combination with clemastine, on allergen-induced cutaneous wheal-and-flare reaction in human skin
137. Direct effects of H2-receptor antagonists on airway smooth muscle and on responses mediated by H1- and H2-receptors
138. H1- and H2-antagonists in allergic and pseudoallergic diseases
139. H1 and H2 blockade: A prophylactic principle in anaesthesia and surgery against histamine-release responses of any degree of severity: Pt II
140. Histaminel-histamine2 antagonism: Effect of combined clemastine and cimetidine pretreatment on allergen and histamine-induced reactions of the guinea pig lung in vivo and in vitro
141. The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reations
142. H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: A critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs
143. The use of H1 and H2 histamine antagonists with morphine anesthesia: A double-blind study
144. Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high-dose atracurium for rapid sequence endotracheal intubation
145. Effect of oral antihistamine premedication on mivacurium-induced histamine release and side effects
146. Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions
147. Antihistamine prophylaxis permits rapid vancomycin infusion
148. Decreased incidence and mortality of anaphylaxis to chymopapain
149. Incidence and clinical importance of perioperative histamine release: Randomised study of volume loading and antihistamines after induction of anaesthesia. Trial Group Mainz/Marburg
150. Antihistamine prophylaxis and general anaesthesia
151. Latex allergy: Failure of prophylaxis to prevent severe reaction
152. Latex hypersensitivity in children Clinical presentation and detection of latex-specific immunoglobulin E
153. Anaphylactoid reaction to ranitidine in an obstetric patient
154. Latex anaphylaxis causing heart block: Role of ranitidine
155. Allergic reactions during anaesthesia
156. Allergy during anaesthesia
157. Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1
158. Hapten inhibition and dextran anaphylaxis
159. Prevention of dextran anaphylaxis: Ten years experience with hapten dextran
160. Serious complications with dextran-70 despite hapten prophylaxis: Is it best avoided prior to delivery?
161. Anaphylactic reactions to suxamethonium: Prevention of mediator release by choline
162. Rapid pre-operatire immunotherapy in a patient allergic to muscle relaxants
163. Prevention by monovalent haptens of IgE-dependent leucocyte histamine release to muscle relaxants
164. Routine testing for latex allergy in patients with spina bifida
165. Latex-specific IgE, skin testing, and lymphocyte transformation to latex in latex allergy
166. Is systematic preoperative screening for muscle relaxant and latex allergy advisable?
167. Allergic and pseudo-allergic reactions in anesthesia I: Pathogenesis, risk factors, substances
168. Do latex precautions in children with myelodysplasia reduce intraoperatire allergic reactions?
169. Clinical management of latex-allergic children
170. A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room
171. Choc anaphylactique peranesthesique: Conduite a tenir
172. Immunology: Allergy and anaesthesia
173. The use of epinephrine in the treatment of anaphylaxis: American Academy of Allergy and Immunology board of Directors
174. Anaphylaxis
175. Comparison of subcutaneous injection and high-dose inhalation of epinephrine: Implications for self-treatment to prevent anaphylaxis
176. Epinephrine absorption in children with a history of anaphylaxis
177. Inhaled adrenaline in the treatment of anaphylaxis
178. Endotracheal administration of emergency medications
179. Endotracheal administration of emergency medications
180. Treatment of acute anaphylaxis: Avoid subcutaneous or intramuscular adrenaline
181. Treatment of acute anaphylaxis: Expressing the dose of adrenaline in milligrams is easier
182. Profound reversible myocardial depression after anaphylaxis
183. New concepts in the treatment of anaphylactoid mactions in anesthesia
184. Role of nitric oxide in anaphylactic shock
185. Use of glucagon in intractable allergic reactions and as an alternative to epinephrine: An interesting case review
186. Glucagon in anaphylaxis
187. Glucagon reversal of hypotension in a case of anaphylactoid shock
188. The mechanisms of antiinflammatory steroid action in allergic diseases
189. Histamine antagonists in the treatment of acute allergic reactions
190. Cimetidine in anaphylactic shock refractory to standard therapy
191. Histamine-2 receptor blocker in the treatment of protamine related anaphylactoid reactions: Two case reports
192. Is cimetidine indicated in the treatment of acute anaphylactic shock